We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,933

Intel exclusivity rebates are inherently anti-competitive
  • CMS Cameron McKenna
  • European Union
  • February 20 2015

The most significant EU competition law judgment of 2014 was the General Court's judgment of 12 June, dismissing an appeal by Intel Corp. against a


Forum shopping in cross-border product liability litigation
  • CMS Cameron McKenna
  • European Union
  • February 20 2015

Defendants to product liability claims brought under the EU's Product Liability Directive 85374EEC, especially defendants in group litigation with


CJEU decision provides certainty for stem cell researchers?
  • CMS Cameron McKenna
  • European Union
  • February 20 2015

On 18 December 2014, the CJEU ruled on the question referred to it by the High Court, in International Stem Cell Corporation v Comptroller General of


Pay-for-delay another patent settlement monitoring report
  • CMS Cameron McKenna
  • European Union
  • February 20 2015

The European Commission's fifth patent settlement monitoring report was published on 5 December 2014. The Commission started monitoring patent


Competition news December 2014 (International French)
  • Dentons
  • European Union, France
  • December 24 2014

La Cour d’appel de Paris vient de réformer une décision de l’Autorité de la Concurrence, en considérant que les accords de commercialisation en


Pharmaceutical & medical device regulatory update, vol. II, issue 8
  • Jones Day
  • European Union, USA
  • April 24 2015

The first U.S. biosimilar product Zarxio overcame another legal challenge earlier this month when a federal court in California denied a motion to


European Data Protection Supervisor Opinion on mobile health
  • Taylor Wessing
  • European Union
  • June 17 2015

The EDPS looks at data protection issues in m-health. What's the issue? From lifestyle and wellbeing apps to apps which monitor and regulate


Protecting personalised medicine at the EPO
  • NLO
  • European Union
  • June 17 2015

Under Article 54(5) of the European Patent Convention (EPC) 2000, known substances or compositions are deemed to be novel if they are intended for


The patentability of stem cells in Europe
  • VO Patents & Trademarks
  • European Union
  • June 17 2015

Stem cells have several applications with the potential for commercialisation. These range from unique services for customers (eg, a cell-based


European Data Protection Supervisor releases opinion on mobile health
  • Alston & Bird LLP
  • European Union
  • June 18 2015

The European Data Protection Supervisor ("EDPS"), Giovanni Buttarelli, has published an opinion on Mobile Health ("mHealth"); a rapidly evolving